Your browser doesn't support javascript.
loading
Protocol for designing INVITES-IN, a tool for assessing the internal validity of in vitro studies.
Svendsen, Camilla; Whaley, Paul; Vist, Gunn E; Husøy, Trine; Beronius, Anna; Consiglio, Emma Di; Druwe, Ingrid; Hartung, Thomas; Hatzi, Vasiliki I; Hoffmann, Sebastian; Hooijmans, Carlijn R; Machera, Kyriaki; Robinson, Joshua F; Roggen, Erwin; Rooney, Andrew A; Roth, Nicolas; Spilioti, Eliana; Spyropoulou, Anastasia; Tcheremenskaia, Olga; Testai, Emanuela; Vinken, Mathieu; Mathisen, Gro H.
Afiliação
  • Svendsen C; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.
  • Whaley P; Department of Chemical Toxicology, Norwegian Institute of Public Health, Oslo, Norway.
  • Vist GE; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.
  • Husøy T; Lancaster Environment Centre, Lancaster University, Lancaster, UK.
  • Beronius A; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.
  • Consiglio ED; Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway.
  • Druwe I; Norwegian Scientific Committee for Food and Environment, Norwegian Institute of Public Health, Oslo, Norway.
  • Hartung T; Department of Food Safety, Norwegian Institute of Public Health, Oslo, Norway.
  • Hatzi VI; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Hoffmann S; Environment & Health Department, Italian National Institute of Health (ISS), Rome, Italy.
  • Hooijmans CR; United States Environmental Protection Agency, Office of Research and Development, Center for Public Health and Environmental Assessments, Research Triangle Park, NC, USA.
  • Machera K; Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA.
  • Robinson JF; CAAT Europe, University of Konstanz, Konstanz, Germany.
  • Roggen E; Laboratory of Toxicological Control of Pesticides, Scientific Directorate of Pesticides' Control and Phytopharmacy, Benaki Phytopathological Institute, Kifissia, Greece.
  • Rooney AA; Evidence-Based Toxicology Collaboration (EBTC), Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA.
  • Roth N; SEH consulting + services, Paderborn, Germany.
  • Spilioti E; Department of Anesthesiology, Pain and Palliative Care, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Spyropoulou A; Laboratory of Toxicological Control of Pesticides, Scientific Directorate of Pesticides' Control and Phytopharmacy, Benaki Phytopathological Institute, Kifissia, Greece.
  • Tcheremenskaia O; Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco (UCSF), CA, USA.
  • Testai E; 3Rs Management and Consulting ApS, Lyngby, Denmark.
  • Vinken M; Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.
  • Mathisen GH; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Evid Based Toxicol ; 1(1): 1-15, 2023 Aug 31.
Article em En | MEDLINE | ID: mdl-38264543
ABSTRACT
This protocol describes the design and development of a tool for evaluation of the internal validity of in vitro studies, which is needed to include the data as evidence in systematic reviews and chemical risk assessments. The tool will be designed specifically to be applied to cell culture studies, including, but not restricted to, studies meeting the new approach methodology (NAM) definition. The tool is called INVITES-IN (IN VITro Experimental Studies INternal validity). In this protocol, three of the four studies that will be performed to create the release version of INVITES-IN are described. In the first study, evaluation of existing assessment tools will be combined with focus group discussions to identify how characteristics of the design or conduct of an in vitro study can affect its internal validity. Bias domains and items considered to be of relevance for in vitro studies will be identified. In the second study, group agreement on internal validity domains and items of importance for in vitro studies will be identified via a modified Delphi methodology. In the third study, the draft version of the tool will be created, based on the data on relevance and importance of bias domains and items collected in Studies 1 and 2. A separate protocol will be prepared for the fourth study, which includes the user testing and validation of the tool, and collection of users' experience.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article